# UCMSC Transplantation in the Treatment of Cartilage Damage

> **NCT02776943** · PHASE1,PHASE2 · UNKNOWN · sponsor: **South China Research Center for Stem Cell and Regenerative Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Cartilage Damage
- Degenerative Osteoarthritis

## Interventions

- **BIOLOGICAL:** umbilical cord mesenchymal stem cells
- **DEVICE:** Hyaluronic acid

## Key facts

- **NCT ID:** NCT02776943
- **Lead sponsor:** South China Research Center for Stem Cell and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776943, "UCMSC Transplantation in the Treatment of Cartilage Damage". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02776943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*